Leigh Baldwin & Co’s Cardinal Health CAH Stock Holding History

Leigh Baldwin & Co’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$353K	Hold	1,484	–	–	0.19%	118
2026 Q1	$314K	Buy	+1,484	New	+$320K	0.2%	118

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Leigh Baldwin & Co's CAH Position: Q2 2026 in Review

Leigh Baldwin & Co held its Cardinal Health (CAH) position steady in Q2 2026 at 1,484 shares worth $353K. The position accounts for 0.19% of the portfolio, ranked #118.

Leigh Baldwin & Co first reported a position in CAH in Q1 2026 and has held it in 2 quarters since. 1,496 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

Leigh Baldwin & Co held 1,484 shares of Cardinal Health worth $353K as of Q2 2026.
Leigh Baldwin & Co left its Cardinal Health share count unchanged in Q2 2026.
Cardinal Health made up 0.19% of Leigh Baldwin & Co's portfolio in Q2 2026, its #118 holding.
Leigh Baldwin & Co first reported a position in Cardinal Health in Q1 2026 and has held it in 2 quarters since.
1,496 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Leigh Baldwin & Co's 13F filing for Q2 2026, filed 13 Aug 2026.